{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:44:44Z","timestamp":1773931484511,"version":"3.50.1"},"reference-count":17,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2026,1,3]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) is increasingly detected at an early stage through national screening programmes, including tumours confined to the submucosa (pT1). Many pT1 CRC are managed by local endoscopic excision, and histological risk assessment is central to determining the need for further treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical and pathology data were analysed for screen-detected pT1 CRC removed by local excision within the English Bowel Cancer Screening Programme (BCSP) between 2021 and 2022. The completeness of data recorded in the Bowel Cancer Screening System (BCSS) was audited against national pathology guidance. Clinicopathological features and subsequent management were described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>1267 pT1 CRC from 1260 patients were identified. BCSS data were available for all cases, although some histological fields were incomplete or coded as \u2018not assessable\u2019. Most tumours were adenocarcinoma, not otherwise specified (NOS) (95.7%) and well-moderately differentiated (90.4%). Venous, lymphatic and perineural invasion were recorded in 8.9%, 9.2% and 1.0% of cases, respectively. Complete local resection (R0) was documented in 643 tumours. Following local excision, 342 pT1 CRC (27.0%) received further treatment, most commonly colorectal resection (287 cases) or repeat local excision (23 cases). Lymph node metastases were reported histologically in 33 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This large, contemporary cohort demonstrates that the English BCSP holds rich clinical and histological data suitable for audit and research. The audit highlights parameters where assessment is constrained by specimen-related factors and where data entry could be improved. These data characterise the histological features of locally excised pT1 CRC and their subsequent management and provide a foundation for future outcome-focused studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jcp-2025-210527","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T18:20:33Z","timestamp":1768587633000},"page":"257-263","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Histological reporting of locally excised pT1 colorectal cancer in the English Bowel Cancer Screening Programme: national audit and cohort description"],"prefix":"10.1136","volume":"79","author":[{"given":"Emma J","family":"Norton","sequence":"first","affiliation":[{"name":"Department of Cellular Pathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2222-4104","authenticated-orcid":false,"given":"Adrian C","family":"Bateman","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2026031905050575000_79.4.257.1","unstructured":"Cancer Research UK . Bowel cancer survival statistics. n.d. Available: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/bowel-cancer\/survival#heading-Three"},{"key":"2026031905050575000_79.4.257.2","doi-asserted-by":"crossref","unstructured":"Brierley J , Gospodarowicz MK , Wittekind C . TNM Classification of Malignant Tumours. Chichester, West Sussex, UK: John Wiley & Sons, 2017.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"2026031905050575000_79.4.257.3","unstructured":"Cancer Research UK . Bowel cancer statistics. n.d. Available: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/bowel-cancer#heading-One"},{"key":"2026031905050575000_79.4.257.4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1242458"},{"key":"2026031905050575000_79.4.257.5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1108\/IJHCQA-11-2016-0169","article-title":"The NHS Bowel cancer screening programme achieves the anticipated survival improvement, but participation must be improved","volume":"31","author":"Borowski","year":"2018","journal-title":"Int J Health Care Qual Assur"},{"key":"2026031905050575000_79.4.257.6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2147\/RMHP.S109116","article-title":"The NHS Bowel Cancer Screening Program: current perspectives on strategies for improvement","volume":"10","author":"Koo","year":"2017","journal-title":"Risk Manag Healthc Policy"},{"key":"2026031905050575000_79.4.257.7","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1177\/00031348221146975","article-title":"Risk Factors for Lymph Node Metastasis and Recurrence in T1 Colorectal Cancer: Analysis of 801 Patients in a Single Institute","volume":"89","author":"Ishikawa","year":"2023","journal-title":"Am Surg"},{"key":"2026031905050575000_79.4.257.8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/his.14915","article-title":"Low PD-L1 expression in immune cells predicts the presence of nodal metastasis in early invasive (pT1) colorectal cancer: a novel tool to tailor surgical treatment","volume":"83","author":"Vocino Trucco","year":"2023","journal-title":"Histopathology"},{"key":"2026031905050575000_79.4.257.9","unstructured":"Bowel cancer screening: pathology guidance on reporting lesions. 2021. Available: https:\/\/www.gov.uk\/government\/publications\/bowel-cancer-screening-reporting-lesions\/bowel-cancer-screening-guidance-on-reporting-lesions"},{"key":"2026031905050575000_79.4.257.10","unstructured":"Loughrey MB , Quirke P , Shepherd NA . Dataset for histopathological reporting of colorectal cancer. Royal College of Pathologists. Standards and datasets for reporting cancers; 2023. Available: https:\/\/www.rcpath.org\/static\/c8b61ba0-ae3f-43f1-85ffd3ab9f17cfe6\/c19a5cd7-3485-44c2-b5e1c87154830582\/G049-Dataset-for-histopathological-reporting-of-colorectal-cancer.pdf"},{"key":"2026031905050575000_79.4.257.11","doi-asserted-by":"publisher","DOI":"10.1136\/jcp-2023-208803"},{"key":"2026031905050575000_79.4.257.12","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/ueg2.12670","article-title":"Variation in the detection of lymphovascular invasion in T1 colorectal cancer and its impact on treatment: A nationwide Dutch study","volume":"12","author":"Schee","year":"2024","journal-title":"United European Gastroenterol J"},{"key":"2026031905050575000_79.4.257.13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.706488","article-title":"Influence of Old Age on Risk of Lymph Node Metastasis and Survival in Patients With T1 Colorectal Cancer: A Population-Based Analysis","volume":"11","author":"Ye","year":"2021","journal-title":"Front Oncol"},{"key":"2026031905050575000_79.4.257.14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/his.14970","article-title":"Pathological features associated with metastasis in patients with early invasive (pT1) colorectal carcinoma in colorectal polyps","volume":"83","author":"Brown","year":"2023","journal-title":"Histopathology"},{"key":"2026031905050575000_79.4.257.15","unstructured":"Healthcare Quality Improvement Partnership (HQIP), Clinical Effectiveness Unit, Royal College of Surgeons of England . National bowel cancer audit patient report 2017: bowel cancer in England and wales. 2017."},{"key":"2026031905050575000_79.4.257.16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17030537","article-title":"Right-Sided Versus Left-Sided Colon Cancer-A 5-Year Single-Center Observational Study","volume":"17","author":"Szostek","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026031905050575000_79.4.257.17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/bjs\/znab168","article-title":"Histopathological risk factors for lymph node metastases in T1 colorectal cancer: meta-analysis","volume":"108","author":"Ebbeh\u00f8j","year":"2021","journal-title":"Br J Surg"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp-2025-210527","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:05:18Z","timestamp":1773921918000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp-2025-210527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,3,19]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/jcp-2025-210527"],"URL":"https:\/\/doi.org\/10.1136\/jcp-2025-210527","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]}}}